| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5875159 | Journal of Stroke and Cerebrovascular Diseases | 2014 | 5 Pages |
Abstract
Thrombolytic therapy is an only determinant factor for stroke evolution in large AChA infarcts, which reduced the risk of stroke evolution and improved functional outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Meng-Chen MD, Li-Kai MD, PhD, Chung-Chu MS, Shin-Joe MD, Sung-Chun MD, PhD, Yun-Ju MS, Chien-Lin MS, Jiann-Shing MD, PhD,